(Q28214116)

childhood acute myeloid leukemia

inferred from title

1 reference

4

Felix Zintl

0 references

Bernd Gruhn

5

object named as

Bernd Gruhn

0 references

Daniel Steinbach

1

object named as

Daniel Steinbach

0 references

author name string

Johann Hermann

2

0 references

Susanne Viehmann

Cancer Genetics and Cytogenetics

3

0 references

language of work or name

English

0 references

publication date

March 2002

0 references

published in

0 references

volume

133

0 references

issue

2

0 references

page(s)

118-23

0 references

cites work

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Simultaneous expression of different immunogenic antigens in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Design and testing of beta-actin primers for RT-PCR that do not co-amplify processed pseudogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Persistence of AML1 rearrangement in peripheral blood cells in t(8;21)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-4608%2801%2900570-2

7 January 2021

10.1016/S0165-4608(01)00570-2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11943337

1 reference

Consolidated OpenCitations Corpus – April 2017